Identifying psychiatric comorbidities that occur following the introduction of hormonal contraception: a scoping review
-
By
-
Amélie Poirier
-
Juliette Fortier
-
Marie-France Marin
-
Marie Désilets
-
Alexandre Hudon
-
June 1, 2026
-
Clinical Scorecard: Exploring Psychiatric Comorbidities Associated with Hormonal Contraceptive Use: A Scoping Review
At a Glance
| Category | Detail |
| Condition | |
| Key Mechanisms | Add source attribution for the claim about hormonal contraceptives disrupting the hypothalamic-pituitary-ovarian axis. |
| Target Population | |
| Care Setting | |
Key Highlights
Guideline-Based Recommendations
Diagnosis
- E
- n
- s
- u
- r
- e
-
- r
- e
- c
- o
- m
- m
- e
- n
- d
- a
- t
- i
- o
- n
- s
-
- a
- r
- e
-
- d
- i
- r
- e
- c
- t
- l
- y
-
- s
- o
- u
- r
- c
- e
- d
-
- f
- r
- o
- m
-
- t
- h
- e
-
- s
- t
- u
- d
- y
-
- o
- r
-
- g
- u
- i
- d
- e
- l
- i
- n
- e
- s
- .
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Add source for the association between progestin-only methods and depressive symptoms.
Clinical Best Practices
Related Resources & Content